Skyrizi (risankizumab-rzaa) is a prescription drug used to treat certain autoimmune conditions, including plaque psoriasis and Crohn’s disease. It works by attaching to specific proteins in your ...

Skyrizi (risankizumab-rzaa) is a biologic medication doctors prescribe to treat certain autoimmune and inflammatory conditions. Like any medication, it can cause side effects. But is one of Skyrizi’s ...

With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...

Please provide your email address to receive an email when new articles are posted on . Most patients with moderate to severe CD who did not initially respond to risankizumab achieved clinical ...

AbbVie sees limited tariff impact due to U.S. manufacturing Skyrizi and Rinvoq sales exceed analyst expectations Venclexta to benefit from Trump's "one big beautiful bill" July 31 (Reuters) - AbbVie ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...